ZyVersa Therapeutics Stock (NASDAQ: ZVSA) stock price, news, charts, stock research, profile.
You can purchase shares of ZyVersa Therapeutics (NASDAQ:ZVSA) through any online brokerage.
Other companies in ZyVersa Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NuCana (NASDAQ:NCNA).
ZyVersa Therapeutics has a consensus price target of $12.00.
The stock price for ZyVersa Therapeutics (NASDAQ: ZVSA) is $1.09 last updated November 22, 2024 at 7:54 PM EST.
There are no upcoming dividends for ZyVersa Therapeutics.
ZyVersa Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for ZyVersa Therapeutics.
ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.